Traduction de «catégorie d'actions » (Français → Anglais) :

class of shares

class of shares

listing of shares of the same class

Definition: A residual category for disorders in which there is some admixture of specific developmental disorders of speech and language, of scholastic skills, and of motor function, but in which none predominates sufficiently to constitute the prime diagnosis. This mixed category should be used only when there is a major overlap between each of these specific developmental disorders. The disorders are usually, but not always, associated with some degree of general impairment of cognitive functions. Thus, the category should be used ...[+++]when there are dysfunctions meeting the criteria for two or more of F80.-, F81.- and F82.

enhanced category 5 cable | category 5e cable | category 5e cabling | category 5+ cable | category 5+ cabling | enhanced cat 5 | category 5e | category 5+ | cat 5e | cat 5+

Definition: This category should be used to record the presence of psychological or behavioural influences thought to have played a major part in the etiology of physical disorders which can be classified to other chapters. Any resulting mental disturbances are usually mild, and often prolonged (such as worry, emotional conflict, apprehension) and do not of themselves justify the use of any of the categories in this chapter. | Psychological factors affecting physical conditions Examples of the use of this category are:asthma F54 and J45.- | dermatitis F54 and L23-L25 | gastri ...[+++]c ulcer F54 and K25.- | mucous colitis F54 and K58.- | ulcerative colitis F54 and K51.- | urticaria F54 and L50.-

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

may permit, where the subscribed capital of a company having several classes of shares carrying different rights with regard to voting, or participation in distributions within the meaning of Article 56 or in assets in the event of liquidation, is increased by issuing new shares in only one of these classes, the right of pre-emption of shareholders of the other classes to be exercised only after the exercise of this right by the shareholders of the class in which the new shares are being issued.

In contrast, where an issuer has shares already admitted to trading on a regulated market, a prospectus should not be required for any subsequent admission of the shares of the same class on the same regulated market, including where such shares result from the conversion or exchange of other securities or from the exercise of the rights conferred by other securities, provided that the newly admitted shares represent a limited proportion in relation to shares of the same class already admitted to the same regulated market, unless such admission is combined with an offer of securities to the public falling within the scope of this Regulat ...[+++]ion.

(2) The number of Class A Shares or Class B Shares of the Corporation, as the case may be, issued on conversion to each holder of Class C Shares, Class D Shares or Equity Debentures of the Corporation shall be such number as results in an aggregate holding by each holder of Class A Shares or Class B Shares, as the case may be, equal to the number of Class A Shares or Class B Shares, as the case may be, that such holder would have held had such holder, or in the case of a Class A holder, its predecessors in title in respect of its Class A Shares, subscribed for and been issued, Class A Shares or Class B Shares, as the case may be, rather ...[+++]than Class D Shares and Equity Debentures.

(in this section, referred to as the “conversion date”) all issued and outstanding Class C Shares, Class D Shares and Equity Debentures of the Corporation held by holders of Class A Shares of the Corporation shall be automatically converted into Class A Shares and all issued and outstanding Class C Shares, Class D Shares and Equity Debentures of the Corporation held by holders of Class B Shares of the Corporation shall be automatically converted into Class B Shares in accordance with subsection (2).